Exact Sciences to report $454-455M in total revenue, 71-percent growth for 2018
167715
post-template-default,single,single-post,postid-167715,single-format-standard,bridge-core-1.0.5,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

Exact Sciences to report $454-455M in total revenue, 71-percent growth for 2018

excat-sciences

Exact Sciences to report $454-455M in total revenue, 71-percent growth for 2018

– Cologuard test volume increased 64 percent, with approximately 934,000 tests completed in 2018

– Nearly 15,000 health care providers ordered their first Cologuard test during the fourth quarter

– We expect approximately 94 percent of patients who completed a Cologuard test during the fourth quarter to have no out-of-pocket costs

READ FULL STORY